MEASLES       Public Website      Pay Statements

Health Canada has approved the temporary import and sale of US English labeled HIKMA vials. The product is considered interchangeable with the Canadian authorized product. Prescribers are asked to refer to the Canadian product monograph as needed.

Supply of pantoprazole 40 mg injection is tenuous, and our current inventory will not meet usage demand without conservation measures.

Conservation measures:

  1. Prescribers need to assess patients on pantoprazole IV therapy to step down to oral therapy as soon as clinically feasible.
  2. For patients with an active gastrointestinal bleed, pantoprazole 40 mg IV twice daily for 72 hours should be prescribed, rather than running a 24-hour continuous IV infusion.
  3. For acutely bleeding patients who have been scoped and found not to have a bleeding peptic ulcer, they should immediately be stepped down to an oral proton pump inhibitor.
  4. Famotidine injection (H2 receptor blocker) supply is tenuous but remains an option.
  5. Esomeprazole-MUPS are freely available for patients who are unable to swallow tablets whole or with tube feeds.

Oral pantoprazole tablets remain freely available.

Due to the pantoprazole injection shortage, alternate brands have been brought in; there may be different brands in use within the same facility. Please note that the JAMP brand pantoprazole injection is INCOMPATIBLE with the MINI-BAG PLUS system.

Thank you for your support of the ongoing efforts to manage drug supply issues. For questions, please contact your site pharmacy Or please contact Rizwan Ahmed via email Or Libby Gair via email.

Submitted by:  Pharmacy Program
For more info. contact:  Rizwan Ahmed, Director – Pharmacy or Libby Gair, Drug Distribution Supervisor

Healthier people. Healthier communities. Thriving together.
Skip to content